1. 167 The New Diabetes Drug Canagliflozin Enhances the Response of Prostate Cancer to Radiotherapy. (October 2019) Authors: Mekhaeil, Bassem; Zacharidis, Panagiotis; Tsakiridis, Evelyn; Biziotis, Olga-Demetra; Broadfield, Lindsay; Menjolian, Gabe; Mathurin, Tammy; Farrell, Thomas; Muti, Paola; Liu, Stanley; Steinberg, Gregory; Tsakiridis, Theodoros Journal: Radiotherapy and oncology Issue: Volume 139(2019)Supplement 1 Page Start: S71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 40 Canagliflozin, a New Anti-Diabetic Agent Targeting Cellular Metabolism, Suppresses Survival and Enhances the Response of Non-Small Cell Lung Cancer (NSCLC) to Radiotherapy. (October 2019) Authors: Biziotis, Olga-Demetra; Tsakiridis, Evangelia - Evelyn; Broadfield, Lindsay; Farrell, Thomas; Menjolian, Gabe; Mathurin, Tammy; Mekhaeil, Bassem; Zacharidis, Panagiotis; Muti, Paola; Abdulkarim, Bassam; Steinberg, Gregory; Tsakiridis, Theodoros Journal: Radiotherapy and oncology Issue: Volume 139(2019)Supplement 1 Page Start: S20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Salicylate enhances the response of prostate cancer to radiotherapy. Issue 5 (4th January 2019) Authors: Broadfield, Lindsay A.; Marcinko, Katarina; Tsakiridis, Evangelia; Zacharidis, Panayiotis G.; Villani, Linda; Lally, James S. V.; Menjolian, Gabe; Maharaj, Danitra; Mathurin, Tammy; Smoke, Marcia; Farrell, Thomas; Muti, Paola; Steinberg, Gregory R.; Tsakiridis, Theodoros Journal: Prostate Issue: Volume 79:Issue 5(2019) Page Start: 489 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗